Latest epilepsy Stories

-- 4 Paws for Ability Service Dogs to Greet Visitors at Eisai Event Booth -- WOODCLIFF LAKE, N.J., April 18, 2013 /PRNewswire/ -- Eisai Inc. announced today that it is a silver level sponsor of the Epilepsy Foundation's 7(th) Annual National Walk for Epilepsy, a family-oriented, non-competitive event to raise awareness and funds to continue fighting to stop seizures, find a cure and overcome the challenges created by epilepsy. The Walk, which unites thousands of families living with...

To Be Presented May 20, 2013 At American Psychiatric Association Annual Meeting in San Francisco LOS ANGELES, April 18, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that the results of the first-ever pediatric clinical trial of external Trigeminal Nerve stimulation (eTNS(TM)) for the treatment of attention-deficit hyperactivity disorder (ADHD) will be presented at the American Psychiatric Association annual meeting in San...

DUBLIN, April 17, 2013 /PRNewswire/ -- Research and Markets announces the addition of "EpiCast Report: Epilepsy - Epidemiology Forecast to 2022" to its catalogue.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Epilepsy affects 50 million people worldwide each year and is one of the most common neurological conditions in the world (WHO, 2005). Epilepsy is defined as a collection of brain dysfunction disorders characterized by recurrent and unpredictable seizures. The...

redOrbit Staff & Wire Reports - Your Universe Online While colic in newborn babies has long been considered to be a gastrointestinal condition, new research suggests that migraine headaches might actually be to blame. The study claims that children who were diagnosed with migraines were more likely (72.6 percent) to experience colic – a condition in which an otherwise healthy infant cries or displays symptoms of distress for long periods of time and for no apparent reason – than...

A new study published on March 6th, 2013 in the journal Acta Neurologica Scandinavica revealed that valproate (Depakote) is linked with birth defects. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) April 12, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and is...

HOUSTON, April 4, 2013 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today provided an update on its recent submission to the Centers for Medicare & Medicaid Services ("CMS") seeking reimbursement coverage for the treatment-resistant depression ("TRD") indication for the VNS Therapy(®) System. As previously announced, the company submitted a request to CMS for reconsideration of coverage for VNS Therapy for TRD and expected to receive a formal acknowledgment from CMS accepting...

The seizures that affect people with temporal-lobe epilepsy usually start in a region of the brain called the hippocampus. But they are often able to involve other areas outside the temporal lobe, propagating via anatomically and functionally connected networks in the brain. New research findings that link decreased brain cell concentration to altered functional connectivity in temporal-lobe epilepsy are reported in an article in Brain Connectivity, a bimonthly peer-reviewed publication from...

EEG could be more widely used to identify treatable causes of common disorders in hospital patients, say researchers in Mayo Clinic Proceedings A retrospective study of patients who had in-hospital electroencephalography (EEG) has established that EEG is a valuable tool that could be deployed more widely to identify treatable causes of impaired consciousness in the hospital setting. The study is published in the April issue of the Mayo Clinic Proceedings. Altered mental status (AMS) and...

- Researchers will study factors influencing optimal epilepsy outcomes ATLANTA, March 25, 2013 /PRNewswire/ -- A research collaboration to analyze the clinical factors that impact epilepsy care and outcomes was announced today by the Department of Neurology at Emory University School of Medicine and UCB, a leading biopharmaceutical company. This work is part of an innovative research collaboration that seeks to identify factors and approaches that achieve optimal response in epilepsy...

UCLA Case Study Results To Be Presented At Major International Status Epilepticus Conference In Salzburg, Austria LOS ANGELES, March 25, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that it will exhibit its CE Mark approved, non-invasive Monarch(TM) eTNS(TM) System for the adjunctive treatment of epilepsy and depression, at the 4th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures to be held in Salzburg, Austria...